Facebook Live: Funding Multiple Sclerosis Research MStranslate December 18, 2018 Community, Research On December 12, 2018, Brett Drummond (our Co-Founder and Chief Science Communicator) held a Facebook Live event to explore the issue of how multiple sclerosis research is...
The Nose Knows: Can Smell Be A Marker Of MS Progression? MStranslate December 6, 2018 Research Research Summary: Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegeneration WHAT? A research study investigating whether specific...
What influences the choice of treatment in MS? MStranslate November 28, 2018 Research, Treatments, Uncategorized Research Summary: Understanding treatment decisions from the perspective of people with relapsing remitting multiple sclerosis: A critical interpretive synthesis The past decade has seen a number of new...
EBV-Specific T Cell Therapy for Progressive MS MStranslate November 20, 2018 Epstein-Barr virus, Infection, Progressive MS, Research, Treatments Research Summary: Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis Last week, during our Facebook Live Q&A, we discussed the potential role of Epstein-Barr Virus or EBV in...
ECTRIMS 2018: The Gut Microbiome in MS MStranslate November 19, 2018 Conferences, ECTRIMS, Research 1 Comment "It is intriguing...can you modulate the gut microbiome to improve outcomes in MS, such as reducing relapse rates? That would be a fabulous end goal!" - Prof Helen Tremlett. The potential role of the gut...
ECTRIMS Congress 2018 Coverage – Day 3 MStranslate October 18, 2018 Conferences, ECTRIMS, Research 1 Comment This year, MStranslate invested in travelling to the ECTRIMS Congress 2018, recognising it’s the easiest and most efficient way to inform our online communities of the important insights and outcomes being...
ECTRIMS Congress 2018 Coverage – Day 2 MStranslate October 15, 2018 Conferences, ECTRIMS, Research 2 Comments This year, MStranslate invested in travelling to the ECTRIMS Congress 2018, recognising it’s the easiest and most efficient way to inform our online communities of the important insights and outcomes being...
ECTRIMS Congress 2018 Coverage – Day 1 MStranslate October 11, 2018 Conferences, ECTRIMS, Research 2 Comments This year, MStranslate has invested in travelling to the ECTRIMS Congress 2018, recognising it's the easiest and most efficient way to inform our online communities of the important insights and outcomes being...
Ocrevus and PPMS: Where to from here? MStranslate September 10, 2018 Ocrelizumab, Opinion, Treatments The following is an opinion piece written by MStranslate co-founder, Brett Drummond. Let’s rewind to last March last year…there is worldwide excitement as ocrelizumab (Ocrevus) becomes the first treatment...
Ibudilast Phase 2 Trial Results for Progressive MS MStranslate August 30, 2018 Progressive MS, Research, Treatments Research Summary: Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis What is it? Ibudilast is an anti-inflammatory treatment, which also has effects that protect nerves. It is thought to offer...
